Protocol to identify genes required for cardiomyocyte development using Perturb-Seq Authors: Sushama Sivakumar, Lei Wang, Huan Zhao, Mpathi Nzima, David C Park, Yihan Wang, Anjana Sundarrajan, Chikara Takeuchi, Minnie Deng, W Lee Kraus, Gary C Hon, Nikhil V Munshi Published: 2026 ABSTRACT SummaryWhile Perturb-Seq combines CRISPR-based screening with single-cell RNA sequencing (scRNA-seq), large-scale experiments are costly and its application during development is complicated by differentiation heterogeneity. Here, we present a protocol to identify genes required for cardiomyocyte development using Perturb-Seq. We describe steps for sgRNA (single guide RNA) library cloning and infection, cardiomyocyte differentiation, cell hashing, super loading, and scRNA-seq. We then detail procedures for sequencing, mapping, and data analysis.For complete details on the use and execution of this protocol, please refer to Sivakumar et al.1Subject areas: Genomics, Sequencing, RNAseq, High Throughput Screening, Molecular Biology, Gene Expression, CRISPR, Stem Cells, Cell Differentiation Before you begin The protocol below is for performing CRISPR interference Perturb-Seq (CRISPRi followed by scRNA-seq) of all transcription factors (TF) in the human genome during cardiomyocyte (CM) differentiation. We have successfully used this protocol to analyze downstream consequences of TF repression during CM and neuron differentiation. Perturb-Seq can be expensive and time-consuming. To ensure success, we detail QC steps at specific time points. Additionally, we provide technical tools that minimize costs and maximize data recovery after scRNA-seq. Perturb-Seq has been successfully performed in immortalized cell lines. In our previous study, we engineered pluripotent stem cell lines (PSCs) with constitutive or inducible expression of dCas9-KRAB (dCK) from a genomic safe harbor locus (classic KRAB-A domain). This allows stable expression of the CRISPRi machinery in a homogenous manner in our cell lines. Upon sgRNA introduction into our cells, we observed consistent repression of target genes to enable Perturb-Seq during developmental stages. Our resources and reagents are publicly available for the scientific community. Innovation This protocol describes steps needed to perform Perturb-Seq during in vitro differentiation from pluripotent stem cells. We detail QC steps we have adopted to ensure success. We list steps taken to maximize efficiency and minimize associated costs. Lastly, we detail how we use Pyspade, an analysis package, to computationally obtain perturbed transcriptomes after scRNA-seq.2 Github page with step by step details can be found at https://github.com/Hon-lab/Perturb-Seq-Processing-Pipeline. Institutional permissions All pluripotent stem cell work done is in accordance with the Stem Cell Research Oversight Committee (SCRO) at UT Southwestern Medical Center (UTSW). Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesCardiac Troponin T Mouse, PE, Clone: 13–11BD BiosciencesCat#564767; RRID: AB_2738939TotalSeq™-C0251 anti-human Hashtag 1 AntibodyBiolegendCat#394661TotalSeq™-C0252 anti-human Hashtag 2 AntibodyBiolegendCat#394663TotalSeq™-C0253 anti-human Hashtag 3 AntibodyBiolegendCat#394665TotalSeq™-C0254 anti-human Hashtag 4 AntibodyBiolegendCat#394667TotalSeq™-C0255 anti-human Hashtag 5 AntibodyBiolegendCat#394669TotalSeq™-C0256 anti-human Hashtag 6 AntibodyBiolegendCat#394671TotalSeq™-C0257 anti-human Hashtag 7 AntibodyBiolegendCat#394673TotalSeq™-C0258 anti-human Hashtag 8 AntibodyBiolegendCat#394675TotalSeq™-C0259 anti-human Hashtag 9 AntibodyBiolegendCat#394677TotalSeq™-C0260 anti-human Hashtag 10 AntibodyBiolegendCat#394679TotalSeq™-C0262 anti-human Hashtag 12 AntibodyBiolegendCat#394683TotalSeq™-C0263 anti-human Hashtag 13 AntibodyBiolegendCat#394685Bacterial and virus strainsStellar™ Competent CellsTakaraCat#636766Chemicals, peptides, and recombinant proteinsSPRIselect ReagentS, 60mLBeckman CoulterCat#B23318ThiazovivinSigmaCat#SML1045B-27 Supplement (50×), serum freeGibcoCat#17504044L-ascorbic acid 2-phosphate trisodium saltSigmaCat#49752; CAS: 66170-10-3RPMI 1640 Medium (Mod.) 1× with L-GlutamineCorningCat#10-041-CVKnockOut Serum ReplacementGibcoCat#10828028N/ACat#OsrHSACritical commercial assaysChromium Next GEM Single Cell 5′ HT Reagent Kits v2 (Dual Index) with Feature Barcode technology for CRISPR Screening and Cell Surface Protein10× GenomicsCat#PN-1000356Chromium Next GEM Single Cell 3′ HT Reagent Kits v3.1 (Dual Index) with Feature Barcode technology for CRISPR Screening & Cell Multiplexing10× GenomicsCat#PN-1000370Deposited dataRaw and Analyzed dataThis paperIGVF Data PortalExperimental models: Cell linesH9-dCKIn houseSivakumar et al1WTC11-dCKIn houseSivakumar et al1 Step-by-step method details sgRNA plasmid library construction Timing: ∼2–4 days Here we aim to clone the sgRNA library into lentiviral backbone (Figure 1). This allows expression of sgRNA library in eukaryotic cells. 1.Curate a list of genes and appropriate sgRNA sequences to obtain target repression. To repress all TFs in the human genome, we obtained sgRNA sequences designed by a previous publication.3 Curate a list of genes and appropriate sgRNA sequences to obtain target repression. To repress all TFs in the human genome, we obtained sgRNA sequences designed by a previous publication.3 2.Synthesize sgRNA oligo sequences commercially. Synthesize sgRNA oligo sequences commercially. Note: Design sgRNA sequences for specific targets using CRISPick or use published and validated sgRNAs. Note: Lenti-Guide(10×) sgRNA library sequence: GTGGAAAGGACGAAACACCGNNNNNNNNNNNNNNNNNNNgtttaagagctaagctggaaacagc 3.Resuspend sgRNA oligo pool with low EDTA TE buffer. [0.5 ng/μL ∼0.024μM]. Resuspend sgRNA oligo pool with low EDTA TE buffer. [0.5 ng/μL ∼0.024μM]. 4.Perform PCR to amplify double-stranded sgRNAs using library-fwd and library-rev primers to yield 139-bp fragments.a.Set up 4 tubes of 50 μL PCR reactions shown below (total 3.2 ng sgRNA oligos): Perform PCR to amplify double-stranded sgRNAs using library-fwd and library-rev primers to yield 139-bp fragments.a.Set up 4 tubes of 50 μL PCR reactions shown below (total 3.2 ng sgRNA oligos): a.Set up 4 tubes of 50 μL PCR reactions shown below (total 3.2 ng sgRNA oligos): Set up 4 tubes of 50 μL PCR reactions shown below (total 3.2 ng sgRNA oligos): PCR reaction master mixReagentsAmountPrimer- F (10 μM) taacttgaaagtatttcgatttcttggctttatatatcttGTGGAAAGGACGAAACACCG2.5 μLPrimer- R (10 μM) gttgataacggactagccttatttaaacttgctatgctgtttccagcttagctcttaaac2.5 μLsgRNA oligo pool (0.5ng/μL: ∼0.024 μM)1.6 μL2× KAPA Hotstart readymix (Roche, Cat#07958935001)25 μLWater20.9 μL PCR reaction master mix PCR cycling conditionsStepsTemperatureTimeCyclesInitial Denaturation95°C30 sec1Denaturation98°C20 sec5 cyclesAnnealing59°C15 secExtension72°C10 secDenaturation98°C20 sec5 cyclesAnnealing65°C15 secExtension72°C10 secFinal extension72°C1 min1Hold4°Cforever– PCR cycling conditions sgRNA plasmid library construction Steps detailing sgRNA library construction in lentiviral backbones and QC steps to ensure sgRNA complexity is maintained throughout the experiment. 5.Combine reactions. Run 1.2% Agarose gel. Combine reactions. Run 1.2% Agarose gel. 6.Purify 139 bp products with Qiagen MinElute Gel Extraction Kit (Qiagen, Cat#28604).a.Purify with 2 MinElute Spin Columns.b.Elute with 12 μL EB buffer for each column (Total 24 μL).c.Measure DNA concentration with Qubit kit. Purify 139 bp products with Qiagen MinElute Gel Extraction Kit (Qiagen, Cat#28604).a.Purify with 2 MinElute Spin Columns.b.Elute with 12 μL EB buffer for each column (Total 24 μL).c.Measure DNA concentration with Qubit kit. a.Purify with 2 MinElute Spin Columns. Purify with 2 MinElute Spin Columns. b.Elute with 12 μL EB buffer for each column (Total 24 μL). Elute with 12 μL EB buffer for each column (Total 24 μL). c.Measure DNA concentration with Qubit kit. Measure DNA concentration with Qubit kit. 7.Perform restriction digestion on lenti backbone to linearize it. Perform restriction digestion on lenti backbone to linearize it. ReagentVolumeLentiguide (10×) BFP Puro15 μgEsp3I15 μLWaterTo 200 μL total 8.Run 0.7% agarose gel to purify the vector. Run 0.7% agarose gel to purify the vector. Note: Plasmid map of LentiGuide(10×)-BFP-Puro (LW203):https://benchling.com/s/seq-cp12NBXnolGQY6NSXY5b?m=slm-GTRPOQU0bCAenT5kHEgB. We insert a single sgRNA into this lentiviral backbone. 9.Purify with two QIAquick Spin Columns (for DNA size between 70 bps and 10 kbps) (Qiagen, Cat#28115) and elute with 35 μL EB buffer for each column.a.Combine two elutions together (105 μL total).b.Measure DNA concentration with Qubit kit. Purify with two QIAquick Spin Columns (for DNA size between 70 bps and 10 kbps) (Qiagen, Cat#28115) and elute with 35 μL EB buffer for each column.a.Combine two elutions together (105 μL total).b.Measure DNA concentration with Qubit kit. a.Combine two elutions together (105 μL total). Combine two elutions together (105 μL total). b.Measure DNA concentration with Qubit kit. Measure DNA concentration with Qubit kit. 10.Assemble the double-stranded sgRNA library into the lentiviral backbone with the NEBuilder HiFi DNA Assembly (NEB, Cat#E2621X).a.Set up 2 tubes of 100 μL reactions shown below:ReagentVolumeDigested LentiGuide(10×)-BFP-Puro1000 ngsgRNA PCR library40 ngNEB HIFI DNA assemble Master Mix50 μLWaterTo total 100 μLb.Incubate at 50°C for 60 min. Assemble the double-stranded sgRNA library into the lentiviral backbone with the NEBuilder HiFi DNA Assembly (NEB, Cat#E2621X).a.Set up 2 tubes of 100 μL reactions shown below:ReagentVolumeDigested LentiGuide(10×)-BFP-Puro1000 ngsgRNA PCR library40 ngNEB HIFI DNA assemble Master Mix50 μLWaterTo total 100 μLb.Incubate at 50°C for 60 min. a.Set up 2 tubes of 100 μL reactions shown below:ReagentVolumeDigested LentiGuide(10×)-BFP-Puro1000 ngsgRNA PCR library40 ngNEB HIFI DNA assemble Master Mix50 μLWaterTo total 100 μL Set up 2 tubes of 100 μL reactions shown below:ReagentVolumeDigested LentiGuide(10×)-BFP-Puro1000 ngsgRNA PCR library40 ngNEB HIFI DNA assemble Master Mix50 μLWaterTo total 100 μL ReagentVolumeDigested LentiGuide(10×)-BFP-Puro1000 ngsgRNA PCR library40 ngNEB HIFI DNA assemble Master Mix50 μLWaterTo total 100 μL b.Incubate at 50°C for 60 min. Incubate at 50°C for 60 min. 11.Purify assembled DNA with 0.8× SPRIselect beads (Beckman Coulter, Cat#B23318).a.Pipette and mix 160 μL (0.8×) SPRIselect beads with 200 μL PCR reactions.b.Incubate at room temperature for 5 min.c.Keep the tube on the magnet until the supernatant is clear.d.With tubes on the magnet, remove the supernatant carefully and discard.e.Wash SPRIselect beads with 500 μL 80% ethanol.f.Repeat steps c-e three times.g.Elute in 20 μL EB buffer.h.Measure DNA concentration with Qubit kit. Purify assembled DNA with 0.8× SPRIselect beads (Beckman Coulter, Cat#B23318).a.Pipette and mix 160 μL (0.8×) SPRIselect beads with 200 μL PCR reactions.b.Incubate at room temperature for 5 min.c.Keep the tube on the magnet until the supernatant is clear.d.With tubes on the magnet, remove the supernatant carefully and discard.e.Wash SPRIselect beads with 500 μL 80% ethanol.f.Repeat steps c-e three times.g.Elute in 20 μL EB buffer.h.Measure DNA concentration with Qubit kit. a.Pipette and mix 160 μL (0.8×) SPRIselect beads with 200 μL PCR reactions. Pipette and mix 160 μL (0.8×) SPRIselect beads with 200 μL PCR reactions. b.Incubate at room temperature for 5 min. Incubate at room temperature for 5 min. c.Keep the tube on the magnet until the supernatant is clear. Keep the tube on the magnet until the supernatant is clear. d.With tubes on the magnet, remove the supernatant carefully and discard. With tubes on the magnet, remove the supernatant carefully and discard. e.Wash SPRIselect beads with 500 μL 80% ethanol. Wash SPRIselect beads with 500 μL 80% ethanol. f.Repeat steps c-e three times. Repeat steps c-e three times. g.Elute in 20 μL EB buffer. Elute in 20 μL EB buffer. h.Measure DNA concentration with Qubit kit. Measure DNA concentration with Qubit kit. 12.Electroporation with Lucigen Endura Duo competent cells (Fisher Scientific. Cat#50-104-7945) (Figure 1).a.Electroporate 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette (BioRad, Cat#1652089) with a MicroPulser Electroporator (BioRad, Cat#1652100) with program Ec1 (1.8 kV one pulse).Note: Electroporate 100 ng plasmid library instead of ligated DNA for pre-made libraries.Note: We typically have big sgRNA libraries (>1000 sgRNA) and prefer electroporation to get >1000× number of sgRNA clones.b.Add 2 mL SOC recovery media.c.Transfer the E.coli to a 14 mL tube.d.Electroporate another 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette with BioRAD MicroPulser Electroporator.e.Add 2 mL SOC recovery media.f.Transfer the E.coli to a 14 mL tube.g.Incubate culture in 37°C shaker at 250 rpm for 1 h.Dilute 2000×, 10000×, and 20000× with 2 μL of E.coli containing media and spread 50 μL each on LB agar plates and incubate at 37°C overnight.h.The next day, count the plated E.coli colonies to ensure that there are >1000 clones per sgRNA in 2 mL of culture.Total Colony Number = Colony Number in a Plate X Dilution factor X Volume of E.coli/SOC (∼4000 μL)/Volume Plated (50 μL)i.Transfer around 4 mL of E.coli/SOC culture in step 12.g to a flask with 300 mL fresh LB + 150 μg/mL ampicillin.j.Incubate at 37°C in a shaker with 200 rpm for 16 h. Electroporation with Lucigen Endura Duo competent cells (Fisher Scientific. Cat#50-104-7945) (Figure 1).a.Electroporate 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette (BioRad, Cat#1652089) with a MicroPulser Electroporator (BioRad, Cat#1652100) with program Ec1 (1.8 kV one pulse).Note: Electroporate 100 ng plasmid library instead of ligated DNA for pre-made libraries.Note: We typically have big sgRNA libraries (>1000 sgRNA) and prefer electroporation to get >1000× number of sgRNA clones.b.Add 2 mL SOC recovery media.c.Transfer the E.coli to a 14 mL tube.d.Electroporate another 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette with BioRAD MicroPulser Electroporator.e.Add 2 mL SOC recovery media.f.Transfer the E.coli to a 14 mL tube.g.Incubate culture in 37°C shaker at 250 rpm for 1 h.Dilute 2000×, 10000×, and 20000× with 2 μL of E.coli containing media and spread 50 μL each on LB agar plates and incubate at 37°C overnight.h.The next day, count the plated E.coli colonies to ensure that there are >1000 clones per sgRNA in 2 mL of culture.Total Colony Number = Colony Number in a Plate X Dilution factor X Volume of E.coli/SOC (∼4000 μL)/Volume Plated (50 μL)i.Transfer around 4 mL of E.coli/SOC culture in step 12.g to a flask with 300 mL fresh LB + 150 μg/mL ampicillin.j.Incubate at 37°C in a shaker with 200 rpm for 16 h. a.Electroporate 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette (BioRad, Cat#1652089) with a MicroPulser Electroporator (BioRad, Cat#1652100) with program Ec1 (1.8 kV one pulse).Note: Electroporate 100 ng plasmid library instead of ligated DNA for pre-made libraries.Note: We typically have big sgRNA libraries (>1000 sgRNA) and prefer electroporation to get >1000× number of sgRNA clones. Electroporate 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette (BioRad, Cat#1652089) with a MicroPulser Electroporator (BioRad, Cat#1652100) with program Ec1 (1.8 kV one pulse).Note: Electroporate 100 ng plasmid library instead of ligated DNA for pre-made libraries.Note: We typically have big sgRNA libraries (>1000 sgRNA) and prefer electroporation to get >1000× number of sgRNA clones. Note: Electroporate 100 ng plasmid library instead of ligated DNA for pre-made libraries. Note: We typically have big sgRNA libraries (>1000 sgRNA) and prefer electroporation to get >1000× number of sgRNA clones. b.Add 2 mL SOC recovery media. Add 2 mL SOC recovery media. c.Transfer the E.coli to a 14 mL tube. Transfer the E.coli to a 14 mL tube. d.Electroporate another 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette with BioRAD MicroPulser Electroporator. Electroporate another 25 μL E.coli + 1 μL ligated DNA (>50 ng) with 0.1 cm cuvette with BioRAD MicroPulser Electroporator. e.Add 2 mL SOC recovery media. Add 2 mL SOC recovery media. f.Transfer the E.coli to a 14 mL tube. Transfer the E.coli to a 14 mL tube. g.Incubate culture in 37°C shaker at 250 rpm for 1 h.Dilute 2000×, 10000×, and 20000× with 2 μL of E.coli containing media and spread 50 μL each on LB agar plates and incubate at 37°C overnight. Incubate culture in 37°C shaker at 250 rpm for 1 h. Dilute 2000×, 10000×, and 20000× with 2 μL of E.coli containing media and spread 50 μL each on LB agar plates and incubate at 37°C overnight. h.The next day, count the plated E.coli colonies to ensure that there are >1000 clones per sgRNA in 2 mL of culture.Total Colony Number = Colony Number in a Plate X Dilution factor X Volume of E.coli/SOC (∼4000 μL)/Volume Plated (50 μL) The next day, count the plated E.coli colonies to ensure that there are >1000 clones per sgRNA in 2 mL of culture. Total Colony Number = Colony Number in a Plate X Dilution factor X Volume of E.coli/SOC (∼4000 μL)/Volume Plated (50 μL) i.Transfer around 4 mL of E.coli/SOC culture in step 12.g to a flask with 300 mL fresh LB + 150 μg/mL ampicillin. Transfer around 4 mL of E.coli/SOC culture in step 12.g to a flask with 300 mL fresh LB + 150 μg/mL ampicillin. j.Incubate at 37°C in a shaker with 200 rpm for 16 h. Incubate at 37°C in a shaker with 200 rpm for 16 h. 13.Pellet the 200 ml E.coli culture. Extract plasmids with Zymo Midiprep kit (Zymo Research, Cat#D4200/D4201) according to the kit protocol.a.Elute plasmids with 200 μL elution buffer several times. Measure the plasmid concentration and merge elutes with the plasmid concentration >1 μg/μL.b.Measure the final DNA concentration after passing through the endo-free column. Pellet the 200 ml E.coli culture. Extract plasmids with Zymo Midiprep kit (Zymo Research, Cat#D4200/D4201) according to the kit protocol.a.Elute plasmids with 200 μL elution buffer several times. Measure the plasmid concentration and merge elutes with the plasmid concentration >1 μg/μL.b.Measure the final DNA concentration after passing through the endo-free column. a.Elute plasmids with 200 μL elution buffer several times. Measure the plasmid concentration and merge elutes with the plasmid concentration >1 μg/μL. Elute plasmids with 200 μL elution buffer several times. Measure the plasmid concentration and merge elutes with the plasmid concentration >1 μg/μL. b.Measure the final DNA concentration after passing through the endo-free column. Measure the final DNA concentration after passing through the endo-free column. Note: Elution is done multiple times since plasmid concentration is high, and repeated elutions are necessary to recover maximal amounts. Bulk sequencing of sgRNAs Timing: ∼1–2 days This section describes procedures to construct next-generation sequencing libraries of sgRNAs, either from the plasmid library described earlier or from genomic DNA where sgRNAs have been integrated into cells. This ensures adequate good sgRNA coverage during the experiment without significant sgRNA dropout or enrichment. Typically, we sequence sgRNAs from 3 samples (Figure 1); the plasmid library, genomic DNA from iPSCs/hESCs before differentiation and genomic DNA from differentiating cells ∼4 days before harvest. 14.For genomic DNA samples, prepare genomic DNA from >2 million cells (or 1000× sgRNA number) using the Qiagen DNeasy Blood & Tissue Kit (Qiagen, Cat#69504).a.Prepare PCR amplicon for NGS bulk sequencing with 10× TT index: Primers needed: For genomic DNA samples, prepare genomic DNA from >2 million cells (or 1000× sgRNA number) using the Qiagen DNeasy Blood & Tissue Kit (Qiagen, Cat#69504).a.Prepare PCR amplicon for NGS bulk sequencing with 10× TT index: Primers needed: a.Prepare PCR amplicon for NGS bulk sequencing with 10× TT index: Primers needed: Prepare PCR amplicon for NGS bulk sequencing with 10× TT index: Primers needed: Fwd-v2: ACACTCTTTCCCTACACGACGCTCTTCCGATCTgaaagtatttcgatttcttggct Rev: GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTaagttgataacggactagcc 10× TT set A index or IDT-synthesized TT set A index Map of sgRNA PCR amplicon v2 Benchling file: https://benchling.com/s/seq-ev18tEY07pX59CNZ075A?m=slm-2MGRsOieiH7dX2Ms3Ecn 15.Prepare 1st round of PCR. Prepare 1st round of PCR. Note: Prepare a master mix for 4–12 tubes of PCR reactions (100 μL per reaction) (calculate PCR reaction volume according to the size of sgRNA library. Set up enough amount of genomic DNA for PCR to make sure the complexity of the sgRNA library). PCR reaction master mixReagentsAmount10 μM Fwd-v2 primer5 μL5 μL 10 μM Rev primer5 μL0.125 μg sgRNA plasmid library (or 0.5 μg genomic DNA)1.6 μL2× KAPA Hotstart readymix(Roche, Cat#7958935001)50 μLWaterTotal 100 μL PCR reaction master mix PCR cycling conditionsStepsTemperatureTimeCyclesInitial Denaturation95°C2 min1Denaturation98°C20 sec21 cycles for genomic DNA or 8 cycles for plasmids (27 cycles for genomic DNA or 15 cycles for plasmids if PCR products from 1st round were sequenced with Nanopore)Annealing55°C20 secExtension72°C20 secFinal extension72°C1 min1Hold4°Cforever– PCR cycling conditions 16.Mix all 100 μL PCR reactions together. To purify:a.Take 100 μL to a 0.2 mL PCR tube and add 60 μL (0.6×) SPRIselect to remove >800bp DNA.b.Incubate for 5 min.c.Keep the tube on the magnet until the supernatant is clear.d.Transfer 150 μL supernatant to a new 0.2 mL PCR tube and add 60 μL SPRIselect.e.Incubate at room temperature for 5 min.f.Keep the tube on the magnet until the supernatant is clear.g.Wash the SPRIselect beads three times with 250 μL 80% ethanol.h.Elute PCR product in 40 μL EB buffer. Mix all 100 μL PCR reactions together. To purify:a.Take 100 μL to a 0.2 mL PCR tube and add 60 μL (0.6×) SPRIselect to remove >800bp DNA.b.Incubate for 5 min.c.Keep the tube on the magnet until the supernatant is clear.d.Transfer 150 μL supernatant to a new 0.2 mL PCR tube and add 60 μL SPRIselect.e.Incubate at room temperature for 5 min.f.Keep the tube on the magnet until the supernatant is clear.g.Wash the SPRIselect beads three times with 250 μL 80% ethanol.h.Elute PCR product in 40 μL EB buffer. a.Take 100 μL to a 0.2 mL PCR tube and add 60 μL (0.6×) SPRIselect to remove >800bp DNA. Take 100 μL to a 0.2 mL PCR tube and add 60 μL (0.6×) SPRIselect to remove >800bp DNA. b.Incubate for 5 min. Incubate for 5 min. c.Keep the tube on the magnet until the supernatant is clear. Keep the tube on the magnet until the supernatant is clear. d.Transfer 150 μL supernatant to a new 0.2 mL PCR tube and add 60 μL SPRIselect. Transfer 150 μL supernatant to a new 0.2 mL PCR tube and add 60 μL SPRIselect. e.Incubate at room temperature for 5 min. Incubate at room temperature for 5 min. f.Keep the tube on the magnet until the supernatant is clear. Keep the tube on the magnet until the supernatant is clear. g.Wash the SPRIselect beads three times with 250 μL 80% ethanol. Wash the SPRIselect beads three times with 250 μL 80% ethanol. h.Elute PCR product in 40 μL EB buffer. Elute PCR product in 40 μL EB buffer. Prepare 2nd round PCRReagentsAmount10× plate TT set A primer (or 5 μL 10 μM IDT-synthesized TT set A primers + 15 μL H2O)20 μLPCR1 elution30 μL2× KAPA Hotstart readymix (Roche, Cat# 0795893500)50 μLSet up 2nd round master mix of 1 PCR reaction. Prepare 2nd round PCR Set up 2nd round master mix of 1 PCR reaction. PCR cycling conditionsStepsTemperatureTimeCyclesInitial Denaturation98°C45 sec1Denaturation98°C20 sec8 cyclesAnnealing62°C10 secExtension72°C10 secFinal extension72°C1 min1Hold4°Cforever– PCR cycling conditions 17.Post PCR SPRIselect purification.a.Mix 70 μL (0.7×) SPRIselect with 100 μL PCR products to remove large fragments. Incubate for 5 min.b.Keep the tube on the magnet until the supernatant is clear.c.Transfer 150 μL supernatant to a new tube and add 30 μL SPRIselect.d.Incubate at room temperature for 5 min.e.Keep the tube on the magnet until the supernatant is clear. Wash the SPRIselect beads three times with 250 μL 80% ethanol.f.Elute with 35 μL EB for 275 bps PCR products. Quantify DNA using a Qubit fluorometer and an Agilent TapeStation. Post PCR SPRIselect purification.a.Mix 70 μL (0.7×) SPRIselect with 100 μL PCR products to remove large fragments. Incubate for 5 min.b.Keep the tube on the magnet until the supernatant is clear.c.Transfer 150 μL supernatant to a new tube and add 30 μL SPRIselect.d.Incubate at room temperature for 5 min.e.Keep the tube on the magnet until the supernatant is clear. Wash the SPRIselect beads three times with 250 μL 80% ethanol.f.Elute with 35 μL EB for 275 bps PCR products. Quantify DNA using a Qubit fluorometer and an Agilent TapeStation. a.Mix 70 μL (0.7×) SPRIselect with 100 μL PCR products to remove large fragments. Incubate for 5 min. Mix 70 μL (0.7×) SPRIselect with 100 μL PCR products to remove large fragments. Incubate for 5 min. b.Keep the tube on the magnet until the supernatant is clear. Keep the tube on the magnet until the supernatant is clear. c.Transfer 150 μL supernatant to a new tube and add 30 μL SPRIselect. Transfer 150 μL supernatant to a new tube and add 30 μL SPRIselect. d.Incubate at room temperature for 5 min. Incubate at room temperature for 5 min. e.Keep the tube on the magnet until the supernatant is clear. Wash the SPRIselect beads three times with 250 μL 80% ethanol. Keep the tube on the magnet until the supernatant is clear. Wash the SPRIselect beads three times with 250 μL 80% ethanol. f.Elute with 35 μL EB for 275 bps PCR products. Quantify DNA using a Qubit fluorometer and an Agilent TapeStation. Elute with 35 μL EB for 275 bps PCR products. Quantify DNA using a Qubit fluorometer and an Agilent TapeStation. Note: Expected Qubit fluorometer concentration: 1 to 30 ng/μL Note: Expected library size on TapeStation: 275 bp 18.Nanopore sequencing according to the modified nanopore protocol (Ligation sequencing amplicons - Native Barcoding Kit 24 V14 (SQK-NBD114.24)).a.Briefly, repair and prepare the input amplicon DNA, ligate native barcodes and sequencing adaptors, load the libraries into either MinION or PromethION flowcell.b.The three modifications are:i.Changing “Add 15 μL of resuspended AMPure XP Beads” to “Add 19 μL of resuspended AMPure XP Beads” in End-prepii.Changing “0.4× AMPure XP beads (AXP)” to “1.0× AMPure XP beads (AXP)” in Native barcode ligationiii.Changing “Add 20 μL of resuspended AMPure XP beads (AXP)” to “Add 50 μL of resuspended AMPure XP beads (AXP)” in Adapter ligation and clean-up. Nanopore sequencing according to the modified nanopore protocol (Ligation sequencing amplicons - Native Barcoding Kit 24 V14 (SQK-NBD114.24)).a.Briefly, repair and prepare the input amplicon DNA, ligate native barcodes and sequencing adaptors, load the libraries into either MinION or PromethION flowcell.b.The three modifications are:i.Changing “Add 15 μL of resuspended AMPure XP Beads” to “Add 19 μL of resuspended AMPure XP Beads” in End-prepii.Changing “0.4× AMPure XP beads (AXP)” to “1.0× AMPure XP beads (AXP)” in Native barcode ligationiii.Changing “Add 20 μL of resuspended AMPure XP beads (AXP)” to “Add 50 μL of resuspended AMPure XP beads (AXP)” in Adapter ligation and clean-up. a.Briefly, repair and prepare the input amplicon DNA, ligate native barcodes and sequencing adaptors, load the libraries into either MinION or PromethION flowcell. Briefly, repair and prepare the input amplicon DNA, ligate native barcodes and sequencing adaptors, load the libraries into either MinION or PromethION flowcell. b.The three modifications are:i.Changing “Add 15 μL of resuspended AMPure XP Beads” to “Add 19 μL of resuspended AMPure XP Beads” in End-prepii.Changing “0.4× AMPure XP beads (AXP)” to “1.0× AMPure XP beads (AXP)” in Native barcode ligationiii.Changing “Add 20 μL of resuspended AMPure XP beads (AXP)” to “Add 50 μL of resuspended AMPure XP beads (AXP)” in Adapter ligation and clean-up. The three modifications are:i.Changing “Add 15 μL of resuspended AMPure XP Beads” to “Add 19 μL of resuspended AMPure XP Beads” in End-prepii.Changing “0.4× AMPure XP beads (AXP)” to “1.0× AMPure XP beads (AXP)” in Native barcode ligationiii.Changing “Add 20 μL of resuspended AMPure XP beads (AXP)” to “Add 50 μL of resuspended AMPure XP beads (AXP)” in Adapter ligation and clean-up. i.Changing “Add 15 μL of resuspended AMPure XP Beads” to “Add 19 μL of resuspended AMPure XP Beads” in End-prep Changing “Add 15 μL of resuspended AMPure XP Beads” to “Add 19 μL of resuspended AMPure XP Beads” in End-prep ii.Changing “0.4× AMPure XP beads (AXP)” to “1.0× AMPure XP beads (AXP)” in Native barcode ligation Changing “0.4× AMPure XP beads (AXP)” to “1.0× AMPure XP beads (AXP)” in Native barcode ligation iii.Changing “Add 20 μL of resuspended AMPure XP beads (AXP)” to “Add 50 μL of resuspended AMPure XP beads (AXP)” in Adapter ligation and clean-up. Changing “Add 20 μL of resuspended AMPure XP beads (AXP)” to “Add 50 μL of resuspended AMPure XP beads (AXP)” in Adapter ligation and clean-up. Lentivirus production Timing: ∼1 week The purpose of this section is to package lentivirus using HEK293 cells; purify, concentrate, and store virus until it can be used to infect PSCs. 19.Before you begin, seed HEK293T cells at 5.5 × 106 cells per 10 cm dish in 10 mL DMEM (Sigma Aldrich, Cat#D5796-500 mL with 10% FBS and 1% Pen Strep). Before you begin, seed HEK293T cells at 5.5 × 106 cells per 10 cm dish in 10 mL DMEM (Sigma Aldrich, Cat#D5796-500 mL with 10% FBS and 1% Pen Strep). 20.Incubate for 24 h. Incubate for 24 h. 21.Perform transfection using Transporter 5 reagent (Kyfora Bio, Cat#26008-50) as listed below:Note: Check cell health. Do not proceed if cell density or health is not correct for transfectiona.Mix the DNA in a sterile tube. Scale according to the number of plates to be transfected.DNAAmount for 10-cm dishtransgene8 μgpsPAX26 μgpMD2G2 μgb.Add 1 mL of Opti-MEM per plate to the tube, mix/vortex.c.Add 64 μL Transporter 5 transfection reagent per plate to the tube, vortex for 5 seconds, gently spin down.d.Incubate at room temperature for 20 min.e.Gently pipette up and down 3 times to mix, then gently add 1 mL per plate to cells, spreading around the plate.f.Gently swish media around the dish to evenly distribute the mixture.g.Change the media the next day. Perform transfection using Transporter 5 reagent (Kyfora Bio, Cat#26008-50) as listed below:Note: Check cell health. Do not proceed if cell density or health is not correct for transfectiona.Mix the DNA in a sterile tube. Scale according to the number of plates to be transfected.DNAAmount for 10-cm dishtransgene8 μgpsPAX26 μgpMD2G2 μgb.Add 1 mL of Opti-MEM per plate to the tube, mix/vortex.c.Add 64 μL Transporter 5 transfection reagent per plate to the tube, vortex for 5 seconds, gently spin down.d.Incubate at room temperature for 20 min.e.Gently pipette up and down 3 times to mix, then gently add 1 mL per plate to cells, spreading around the plate.f.Gently swish media around the dish to evenly distribute the mixture.g.Change the media the next day. Note: Check cell health. Do not proceed if cell density or health is not correct for transfection a.Mix the DNA in a sterile tube. Scale according to the number of plates to be transfected.DNAAmount for 10-cm dishtransgene8 μgpsPAX26 μgpMD2G2 μg Mix the DNA in a sterile tube. Scale according to the number of plates to be transfected.DNAAmount for 10-cm dishtransgene8 μgpsPAX26 μgpMD2G2 μg DNAAmount for 10-cm dishtransgene8 μgpsPAX26 μgpMD2G2 μg b.Add 1 mL of Opti-MEM per plate to the tube, mix/vortex. Add 1 mL of Opti-MEM per plate to the tube, mix/vortex. c.Add 64 μL Transporter 5 transfection reagent per plate to the tube, vortex for 5 seconds, gently spin down. Add 64 μL Transporter 5 transfection reagent per plate to the tube, vortex for 5 seconds, gently spin down. d.Incubate at room temperature for 20 min. Incubate at room temperature for 20 min. e.Gently pipette up and down 3 times to mix, then gently add 1 mL per plate to cells, spreading around the plate. Gently pipette up and down 3 times to mix, then gently add 1 mL per plate to cells, spreading around the plate. f.Gently swish media around the dish to evenly distribute the mixture. Gently swish media around the dish to evenly distribute the mixture. g.Change the media the next day. Change the media the next day. 22.Collect virus 48 h after the media change:a.For ultracentrifugation (UC), pre-chill Beckman Optima XL-100 K centrifuge to 4°C.b.Draw media with virus up into a 10 mL or larger syringe.c.Attach a 0.45 μm filter and filter the virus into sterile tube(s) of appropriate size and type. Collect virus 48 h after the media change:a.For ultracentrifugation (UC), pre-chill Beckman Optima XL-100 K centrifuge to 4°C.b.Draw media with virus up into a 10 mL or larger syringe.c.Attach a 0.45 μm filter and filter the virus into sterile tube(s) of appropriate size and type. a.For ultracentrifugation (UC), pre-chill Beckman Optima XL-100 K centrifuge to 4°C. For ultracentrifugation (UC), pre-chill Beckman Optima XL-100 K centrifuge to 4°C. b.Draw media with virus up into a 10 mL or larger syringe. Draw media with virus up into a 10 mL or larger syringe. c.Attach a 0.45 μm filter and filter the virus into sterile tube(s) of appropriate size and type. Attach a 0.45 μm filter and filter the virus into sterile tube(s) of appropriate size and type. 23.To concentrate the virus:a.Transfer filtered virus to ultracentrifuge tubes at 25–30 mL per tube. Supplement with DMEM if needed.b.Concentrate virus with the SW28 Rotor at 25000 rpm at 4°C for 90 min.c.Pour out supernatant.d.Resuspend in the appropriate volume of complete mTeSR plus+CloneR2. To concentrate the virus:a.Transfer filtered virus to ultracentrifuge tubes at 25–30 mL per tube. Supplement with DMEM if needed.b.Concentrate virus with the SW28 Rotor at 25000 rpm at 4°C for 90 min.c.Pour out supernatant.d.Resuspend in the appropriate volume of complete mTeSR plus+CloneR2. a.Transfer filtered virus to ultracentrifuge tubes at 25–30 mL per tube. Supplement with DMEM if needed. Transfer filtered virus to ultracentrifuge tubes at 25–30 mL per tube. Supplement with DMEM if needed. b.Concentrate virus with the SW28 Rotor at 25000 rpm at 4°C for 90 min. Concentrate virus with the SW28 Rotor at 25000 rpm at 4°C for 90 min. c.Pour out supernatant. Pour out supernatant. d.Resuspend in the appropriate volume of complete mTeSR plus+CloneR2. Resuspend in the appropriate volume of complete mTeSR plus+CloneR2. 24.Use virus fresh for highest titer, store at 4°C for up to 3 days, or aliquot and store at −80°C for long term. Use virus fresh for highest titer, store at 4°C for up to 3 days, or aliquot and store at −80°C for long term. Infection of ESC/iPSC expressing dCas9 KRAB with lentiviral sgRNA library Timing: ∼1 week Measure titer of lentiviral sgRNA library and infect appropriate number of PSCs (expressing dCK) to obtain expected multiplicity of infection (MOI). We typically do MOI <=0.3 to get single sgRNA per cell. For larger sgRNA libraries, we aim for MOI of 3 that translates to 2–4 sgRNAs/cell. We only do higher MOI when sgRNA efficiency is low (when non-coding regions are targeted) or some sgRNA target genes that don’t function in cell type of interest (sgRNA library targets diverse genes that are not all functional in particular cell type). 25.Detach cultured PSCs into a single-cell suspension for lentiviral infection.a.Remove media from cells, wash with 2 mL PBS (Corning, Cat#21-031-cv), remove PBS.b.Add 1 mL TrypLE Select (Gibco, Cat#12563-029) and incubate at 37°C for up to 15 min. Check every 3 min and proceed to the next step when cells are rounded and able to detach with a firm tap to the plate.c.Pipette the cells to dissociate them, then add 4 mL PBS to neutralize.d.Spin at 300 g for 5 min. If needed, dislodge cells from the sides of the tube and spin down again. Carefully remove supernatant.e.Resuspend pellet in mTeSR Plus (StemCell Technologies, Cat#100-0276) + 10 μM Rock Inhibitor (Tocris, Cat#Bioscience 1254/10). Pipette thoroughly to break up remaining cell clusters.f.Spin at 300 g for 5 min. Carefully remove supernatant.g.Resuspend pellet in an appropriate volume of media depending on usage. Detach cultured PSCs into a single-cell suspension for lentiviral infection.a.Remove media from cells, wash with 2 mL PBS (Corning, Cat#21-031-cv), remove PBS.b.Add 1 mL TrypLE Select (Gibco, Cat#12563-029) and incubate at 37°C for up to 15 min. Check every 3 min and proceed to the next step when cells are rounded and able to detach with a firm tap to the plate.c.Pipette the cells to dissociate them, then add 4 mL PBS to neutralize.d.Spin at 300 g for 5 min. If needed, dislodge cells from the sides of the tube and spin down again. Carefully remove supernatant.e.Resuspend pellet in mTeSR Plus (StemCell Technologies, Cat#100-0276) + 10 μM Rock Inhibitor (Tocris, Cat#Bioscience 1254/10). Pipette thoroughly to break up remaining cell clusters.f.Spin at 300 g for 5 min. Carefully remove supernatant.g.Resuspend pellet in an appropriate volume of media depending on usage. a.Remove media from cells, wash with 2 mL PBS (Corning, Cat#21-031-cv), remove PBS. Remove media from cells, wash with 2 mL PBS (Corning, Cat#21-031-cv), remove PBS. b.Add 1 mL TrypLE Select (Gibco, Cat#12563-029) and incubate at 37°C for up to 15 min. Check every 3 min and proceed to the next step when cells are rounded and able to detach with a firm tap to the plate. Add 1 mL TrypLE Select (Gibco, Cat#12563-029) and incubate at 37°C for up to 15 min. Check every 3 min and proceed to the next step when cells are rounded and able to detach with a firm tap to the plate. c.Pipette the cells to dissociate them, then add 4 mL PBS to neutralize. Pipette the cells to dissociate them, then add 4 mL PBS to neutralize. d.Spin at 300 g for 5 min. If needed, dislodge cells from the sides of the tube and spin down again. Carefully remove supernatant. Spin at 300 g for 5 min. If needed, dislodge cells from the sides of the tube and spin down again. Carefully remove supernatant. e.Resuspend pellet in mTeSR Plus (StemCell Technologies, Cat#100-0276) + 10 μM Rock Inhibitor (Tocris, Cat#Bioscience 1254/10). Pipette thoroughly to break up remaining cell clusters. Resuspend pellet in mTeSR Plus (StemCell Technologies, Cat#100-0276) + 10 μM Rock Inhibitor (Tocris, Cat#Bioscience 1254/10). Pipette thoroughly to break up remaining cell clusters. f.Spin at 300 g for 5 min. Carefully remove supernatant. Spin at 300 g for 5 min. Carefully remove supernatant. g.Resuspend pellet in an appropriate volume of media depending on usage. Resuspend pellet in an appropriate volume of media depending on usage. 26.Measure the titer of a lentivirus infected into H9/WTC11 cells.a.Culture target cells to 80% confluency (∼2 M cells per well). Check cell health and density.b.Do not proceed if cells look abnormal or overgrown.c.4–5 h before infection, replace culture media with media containing CloneR2.d.Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL media+ 10 μM Rock inhibitor per 2 wells collected.e.Count and check cell viability. Repeat wash if viability is less than 80%. Do not proceed if less than 80% live cells.Aliquot the appropriate number of cells - 1 M cells per condition. Spin at 300 g for 5 min at room temperature. Remove supernatant completely.f.Resuspend cell pellet in media+CloneR2 at 1 million cells per 1 mL. Transfer to clean wells of a 6 well Ultra-Low Attachment Tissue Culture plate.g.Add virus – 10 μL, 50 μL, 200 μL are usually good starting points. Gently tap/shake the plate to mix.Optional: If using concentrated virus, spike in at 10% with a different fluorophore to help estimate MOI.h.Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension.i.After 3 h, plate the cells to a new 6-well Matrigel (Corning, Cat#354277) coated plates with an additional 1 mL media+CloneR2. Incubate the cells in a humidified 37°C/5% CO2 incubator.j.Change the mTeSR Plus media (StemCell Technologies, Cat#100-0276) the next day.k.Measure titer 2 days later:i.Collect cells per the Single Cell Suspension protocol. Resuspend cell pellet at ∼10 M cells per mL (∼100–200 μL per well).ii.Measure BFP+ cells using a flow cytometer, where the BFP+ % is the approximate MOI of that condition, keeping in mind that the actual MOI will be 10 times higher if the virus was diluted to 10% in a different fluorophore.iii.Calculate the appropriate amount of virus for full-scale infection, taking into account a ∼10% loss in infectivity due to storing the virus in 4°C for 2 days. Measure the titer of a lentivirus infected into H9/WTC11 cells.a.Culture target cells to 80% confluency (∼2 M cells per well). Check cell health and density.b.Do not proceed if cells look abnormal or overgrown.c.4–5 h before infection, replace culture media with media containing CloneR2.d.Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL media+ 10 μM Rock inhibitor per 2 wells collected.e.Count and check cell viability. Repeat wash if viability is less than 80%. Do not proceed if less than 80% live cells.Aliquot the appropriate number of cells - 1 M cells per condition. Spin at 300 g for 5 min at room temperature. Remove supernatant completely.f.Resuspend cell pellet in media+CloneR2 at 1 million cells per 1 mL. Transfer to clean wells of a 6 well Ultra-Low Attachment Tissue Culture plate.g.Add virus – 10 μL, 50 μL, 200 μL are usually good starting points. Gently tap/shake the plate to mix.Optional: If using concentrated virus, spike in at 10% with a different fluorophore to help estimate MOI.h.Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension.i.After 3 h, plate the cells to a new 6-well Matrigel (Corning, Cat#354277) coated plates with an additional 1 mL media+CloneR2. Incubate the cells in a humidified 37°C/5% CO2 incubator.j.Change the mTeSR Plus media (StemCell Technologies, Cat#100-0276) the next day.k.Measure titer 2 days later:i.Collect cells per the Single Cell Suspension protocol. Resuspend cell pellet at ∼10 M cells per mL (∼100–200 μL per well).ii.Measure BFP+ cells using a flow cytometer, where the BFP+ % is the approximate MOI of that condition, keeping in mind that the actual MOI will be 10 times higher if the virus was diluted to 10% in a different fluorophore.iii.Calculate the appropriate amount of virus for full-scale infection, taking into account a ∼10% loss in infectivity due to storing the virus in 4°C for 2 days. a.Culture target cells to 80% confluency (∼2 M cells per well). Check cell health and density. Culture target cells to 80% confluency (∼2 M cells per well). Check cell health and density. b.Do not proceed if cells look abnormal or overgrown. Do not proceed if cells look abnormal or overgrown. c.4–5 h before infection, replace culture media with media containing CloneR2. 4–5 h before infection, replace culture media with media containing CloneR2. d.Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL media+ 10 μM Rock inhibitor per 2 wells collected. Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL media+ 10 μM Rock inhibitor per 2 wells collected. e.Count and check cell viability. Repeat wash if viability is less than 80%. Do not proceed if less than 80% live cells.Aliquot the appropriate number of cells - 1 M cells per condition. Spin at 300 g for 5 min at room temperature. Remove supernatant completely. Count and check cell viability. Repeat wash if viability is less than 80%. Do not proceed if less than 80% live cells. Aliquot the appropriate number of cells - 1 M cells per condition. Spin at 300 g for 5 min at room temperature. Remove supernatant completely. f.Resuspend cell pellet in media+CloneR2 at 1 million cells per 1 mL. Transfer to clean wells of a 6 well Ultra-Low Attachment Tissue Culture plate. Resuspend cell pellet in media+CloneR2 at 1 million cells per 1 mL. Transfer to clean wells of a 6 well Ultra-Low Attachment Tissue Culture plate. g.Add virus – 10 μL, 50 μL, 200 μL are usually good starting points. Gently tap/shake the plate to mix.Optional: If using concentrated virus, spike in at 10% with a different fluorophore to help estimate MOI. Add virus – 10 μL, 50 μL, 200 μL are usually good starting points. Gently tap/shake the plate to mix.Optional: If using concentrated virus, spike in at 10% with a different fluorophore to help estimate MOI. Optional: If using concentrated virus, spike in at 10% with a different fluorophore to help estimate MOI. h.Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension. Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension. i.After 3 h, plate the cells to a new 6-well Matrigel (Corning, Cat#354277) coated plates with an additional 1 mL media+CloneR2. Incubate the cells in a humidified 37°C/5% CO2 incubator. After 3 h, plate the cells to a new 6-well Matrigel (Corning, Cat#354277) coated plates with an additional 1 mL media+CloneR2. Incubate the cells in a humidified 37°C/5% CO2 incubator. j.Change the mTeSR Plus media (StemCell Technologies, Cat#100-0276) the next day. Change the mTeSR Plus media (StemCell Technologies, Cat#100-0276) the next day. k.Measure titer 2 days later:i.Collect cells per the Single Cell Suspension protocol. Resuspend cell pellet at ∼10 M cells per mL (∼100–200 μL per well).ii.Measure BFP+ cells using a flow cytometer, where the BFP+ % is the approximate MOI of that condition, keeping in mind that the actual MOI will be 10 times higher if the virus was diluted to 10% in a different fluorophore.iii.Calculate the appropriate amount of virus for full-scale infection, taking into account a ∼10% loss in infectivity due to storing the virus in 4°C for 2 days. Measure titer 2 days later:i.Collect cells per the Single Cell Suspension protocol. Resuspend cell pellet at ∼10 M cells per mL (∼100–200 μL per well).ii.Measure BFP+ cells using a flow cytometer, where the BFP+ % is the approximate MOI of that condition, keeping in mind that the actual MOI will be 10 times higher if the virus was diluted to 10% in a different fluorophore.iii.Calculate the appropriate amount of virus for full-scale infection, taking into account a ∼10% loss in infectivity due to storing the virus in 4°C for 2 days. i.Collect cells per the Single Cell Suspension protocol. Resuspend cell pellet at ∼10 M cells per mL (∼100–200 μL per well). Collect cells per the Single Cell Suspension protocol. Resuspend cell pellet at ∼10 M cells per mL (∼100–200 μL per well). ii.Measure BFP+ cells using a flow cytometer, where the BFP+ % is the approximate MOI of that condition, keeping in mind that the actual MOI will be 10 times higher if the virus was diluted to 10% in a different fluorophore. Measure BFP+ cells using a flow cytometer, where the BFP+ % is the approximate MOI of that condition, keeping in mind that the actual MOI will be 10 times higher if the virus was diluted to 10% in a different fluorophore. iii.Calculate the appropriate amount of virus for full-scale infection, taking into account a ∼10% loss in infectivity due to storing the virus in 4°C for 2 days. Calculate the appropriate amount of virus for full-scale infection, taking into account a ∼10% loss in infectivity due to storing the virus in 4°C for 2 days. 27.Infect lentiviral sgRNA library into H9/WTC11 cells at the expected MOI.Note: The protocol below is similar to the titer infection but with more cells and a single virus quantity to obtain the desired MOI. This infection is 2 days after the titer infection, using the same batch of virus.a.Culture target cells to 80% confluency (∼2 million cells per well).b.Check cell health and density. Do not proceed if cells look abnormal or overgrown.c.4–5 h before infection, replace culture media with media containing CloneR2.d.Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL per 2 wells collected.e.Count and aliquot the appropriate number of cells. Spin at 300 g for 5 min at room temperature. Remove the supernatant completely.f.Check cell viability. Repeat wash if viability is less than 80%. Do not proceed if still less than 80% live.g.Resuspend cell pellet in 1 mL media+CloneR2 per 1 million cells.h.Add the appropriate amount of virus. Invert the tube several times to mix.i.Transfer to a clean 6-well Ultra-Low Attachment Tissue Culture plate at 1 million cells per well.j.Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension.k.After 3 h, combine all cells and add media+CloneR2 to 500 k cells per mL.l.Plate 2 mL (1 million cells) per well to new 6-well Matrigel coated plates. Incubate the cells in a humidified 37°C/5% CO2 incubator.m.Change the media the next day.n.Incubate the cells in a humidified 37°C/5% CO2 incubator until sorted. Media change for the cells every 1–2 days. Split them as needed, maintaining the complexity of the cell library.o.Terminate experiment if:i.Viability of cells is <50% or is too low to maintain library complexity.ii.Cells appear unhealthy.iii.Expression of marker fluorophore is much lower than expected.p.Take a representative picture before the first split to estimate integration efficiency. Infect lentiviral sgRNA library into H9/WTC11 cells at the expected MOI.Note: The protocol below is similar to the titer infection but with more cells and a single virus quantity to obtain the desired MOI. This infection is 2 days after the titer infection, using the same batch of virus.a.Culture target cells to 80% confluency (∼2 million cells per well).b.Check cell health and density. Do not proceed if cells look abnormal or overgrown.c.4–5 h before infection, replace culture media with media containing CloneR2.d.Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL per 2 wells collected.e.Count and aliquot the appropriate number of cells. Spin at 300 g for 5 min at room temperature. Remove the supernatant completely.f.Check cell viability. Repeat wash if viability is less than 80%. Do not proceed if still less than 80% live.g.Resuspend cell pellet in 1 mL media+CloneR2 per 1 million cells.h.Add the appropriate amount of virus. Invert the tube several times to mix.i.Transfer to a clean 6-well Ultra-Low Attachment Tissue Culture plate at 1 million cells per well.j.Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension.k.After 3 h, combine all cells and add media+CloneR2 to 500 k cells per mL.l.Plate 2 mL (1 million cells) per well to new 6-well Matrigel coated plates. Incubate the cells in a humidified 37°C/5% CO2 incubator.m.Change the media the next day.n.Incubate the cells in a humidified 37°C/5% CO2 incubator until sorted. Media change for the cells every 1–2 days. Split them as needed, maintaining the complexity of the cell library.o.Terminate experiment if:i.Viability of cells is <50% or is too low to maintain library complexity.ii.Cells appear unhealthy.iii.Expression of marker fluorophore is much lower than expected.p.Take a representative picture before the first split to estimate integration efficiency. Note: The protocol below is similar to the titer infection but with more cells and a single virus quantity to obtain the desired MOI. This infection is 2 days after the titer infection, using the same batch of virus. a.Culture target cells to 80% confluency (∼2 million cells per well). Culture target cells to 80% confluency (∼2 million cells per well). b.Check cell health and density. Do not proceed if cells look abnormal or overgrown. Check cell health and density. Do not proceed if cells look abnormal or overgrown. c.4–5 h before infection, replace culture media with media containing CloneR2. 4–5 h before infection, replace culture media with media containing CloneR2. d.Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL per 2 wells collected. Prepare the cells per the Single Cell Suspension protocol. Resuspend in ∼1 mL per 2 wells collected. e.Count and aliquot the appropriate number of cells. Spin at 300 g for 5 min at room temperature. Remove the supernatant completely. Count and aliquot the appropriate number of cells. Spin at 300 g for 5 min at room temperature. Remove the supernatant completely. f.Check cell viability. Repeat wash if viability is less than 80%. Do not proceed if still less than 80% live. Check cell viability. Repeat wash if viability is less than 80%. Do not proceed if still less than 80% live. g.Resuspend cell pellet in 1 mL media+CloneR2 per 1 million cells. Resuspend cell pellet in 1 mL media+CloneR2 per 1 million cells. h.Add the appropriate amount of virus. Invert the tube several times to mix. Add the appropriate amount of virus. Invert the tube several times to mix. i.Transfer to a clean 6-well Ultra-Low Attachment Tissue Culture plate at 1 million cells per well. Transfer to a clean 6-well Ultra-Low Attachment Tissue Culture plate at 1 million cells per well. j.Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension. Incubate cells in humidified 37°C/5% CO2 for 3 h, either on a plate shaker or tapping/shaking the plate every ∼30 min to keep the cells in suspension. k.After 3 h, combine all cells and add media+CloneR2 to 500 k cells per mL. After 3 h, combine all cells and add media+CloneR2 to 500 k cells per mL. l.Plate 2 mL (1 million cells) per well to new 6-well Matrigel coated plates. Incubate the cells in a humidified 37°C/5% CO2 incubator. Plate 2 mL (1 million cells) per well to new 6-well Matrigel coated plates. Incubate the cells in a humidified 37°C/5% CO2 incubator. m.Change the media the next day. Change the media the next day. n.Incubate the cells in a humidified 37°C/5% CO2 incubator until sorted. Media change for the cells every 1–2 days. Split them as needed, maintaining the complexity of the cell library. Incubate the cells in a humidified 37°C/5% CO2 incubator until sorted. Media change for the cells every 1–2 days. Split them as needed, maintaining the complexity of the cell library. o.Terminate experiment if:i.Viability of cells is <50% or is too low to maintain library complexity.ii.Cells appear unhealthy.iii.Expression of marker fluorophore is much lower than expected. Terminate experiment if:i.Viability of cells is <50% or is too low to maintain library complexity.ii.Cells appear unhealthy.iii.Expression of marker fluorophore is much lower than expected. i.Viability of cells is <50% or is too low to maintain library complexity. Viability of cells is <50% or is too low to maintain library complexity. ii.Cells appear unhealthy. Cells appear unhealthy. iii.Expression of marker fluorophore is much lower than expected. Expression of marker fluorophore is much lower than expected. p.Take a representative picture before the first split to estimate integration efficiency. Take a representative picture before the first split to estimate integration efficiency. FACS sorting for BFP+ sgRNA library-infected PSCs Timing: ∼1 day The purpose is to enrich sgRNA infected PSCs by sorting for BFP (reporter that is part of the sgRNA construct). 28.To sort cells:a.Prepare the cells per the Single Cell Suspension protocol. Resuspend cells in media+Rock Inhibitor to ∼10 million cells/mL.b.Meanwhile, prepare 15 mL conical tubes to sort into by adding 2 mL media+Rock Inhibitor and thoroughly wetting the inside of the tube.c.Strain the cells through a 40 μM strainer into the sample tubes.d.Using a FACS instrument, sort for the desired population of BFP+ cells. Collect into the prepared 15 mL tubes.e.Spin at 300 g for 5 min. Carefully remove supernatant.f.Resuspend pellets in the appropriate amount of media+CloneR2+Normocin.g.Plate cells in 6-well plate - 1 million cells per well.h.Change the media back to complete mTeSR Plus 2 days after the sort.i.Incubate the cells in a humidified 37°C/5% CO2 incubator until differentiation.j.Change media every 1–2 days. Split as needed, maintaining the complexity of the cell library.k.Two weeks after infection, differentiate the cells to cardiomyocytes using the appropriate protocol. To sort cells:a.Prepare the cells per the Single Cell Suspension protocol. Resuspend cells in media+Rock Inhibitor to ∼10 million cells/mL.b.Meanwhile, prepare 15 mL conical tubes to sort into by adding 2 mL media+Rock Inhibitor and thoroughly wetting the inside of the tube.c.Strain the cells through a 40 μM strainer into the sample tubes.d.Using a FACS instrument, sort for the desired population of BFP+ cells. Collect into the prepared 15 mL tubes.e.Spin at 300 g for 5 min. Carefully remove supernatant.f.Resuspend pellets in the appropriate amount of media+CloneR2+Normocin.g.Plate cells in 6-well plate - 1 million cells per well.h.Change the media back to complete mTeSR Plus 2 days after the sort.i.Incubate the cells in a humidified 37°C/5% CO2 incubator until differentiation.j.Change media every 1–2 days. Split as needed, maintaining the complexity of the cell library.k.Two weeks after infection, differentiate the cells to cardiomyocytes using the appropriate protocol. a.Prepare the cells per the Single Cell Suspension protocol. Resuspend cells in media+Rock Inhibitor to ∼10 million cells/mL. Prepare the cells per the Single Cell Suspension protocol. Resuspend cells in media+Rock Inhibitor to ∼10 million cells/mL. b.Meanwhile, prepare 15 mL conical tubes to sort into by adding 2 mL media+Rock Inhibitor and thoroughly wetting the inside of the tube. Meanwhile, prepare 15 mL conical tubes to sort into by adding 2 mL media+Rock Inhibitor and thoroughly wetting the inside of the tube. c.Strain the cells through a 40 μM strainer into the sample tubes. Strain the cells through a 40 μM strainer into the sample tubes. d.Using a FACS instrument, sort for the desired population of BFP+ cells. Collect into the prepared 15 mL tubes. Using a FACS instrument, sort for the desired population of BFP+ cells. Collect into the prepared 15 mL tubes. e.Spin at 300 g for 5 min. Carefully remove supernatant. Spin at 300 g for 5 min. Carefully remove supernatant. f.Resuspend pellets in the appropriate amount of media+CloneR2+Normocin. Resuspend pellets in the appropriate amount of media+CloneR2+Normocin. g.Plate cells in 6-well plate - 1 million cells per well. Plate cells in 6-well plate - 1 million cells per well. h.Change the media back to complete mTeSR Plus 2 days after the sort. Change the media back to complete mTeSR Plus 2 days after the sort. i.Incubate the cells in a humidified 37°C/5% CO2 incubator until differentiation. Incubate the cells in a humidified 37°C/5% CO2 incubator until differentiation. j.Change media every 1–2 days. Split as needed, maintaining the complexity of the cell library. Change media every 1–2 days. Split as needed, maintaining the complexity of the cell library. k.Two weeks after infection, differentiate the cells to cardiomyocytes using the appropriate protocol. Two weeks after infection, differentiate the cells to cardiomyocytes using the appropriate protocol. Note: Cardiomyocyte differentiation is more homogenous when performed two weeks after sgRNA infection. We do not freeze sgRNA infected stem cells to prevent sgRNA dropout upon freeze-thawing and to avoid extra passages before differentiation. Differentiation into cardiomyocytes Timing: 12–15 days Our screen was designed to identify regulators of Cardiomyocyte differentiation. Towards this goal, we differentiated PSCs into cardiomyocytes and performed perturb-seq. 29.Use GiWi protocol to efficiently differentiate ES/iPSCs into cardiomyocytes (Figure 2).Before you begin make CDM3 media:a.CDM3 supplement:i.Slowly add 1.056 g of L-ascorbic acid 2-phosphate (Wako, Cat#USA321-44823) to 50 mL millipore water.ii.Mix intermittently until clear.iii.Add 2.5 g of recombinant human albumin (ScienCell, Cat#OsrHSA), and mix until dissolved.b.Sterilize media using Stericup 0.22 μm vacuum filter (EMD Millipore, Cat#4805)c.Make 5 mL aliquots in 15 mL Falcon tubes and store at −20°C.d.CDM3 complete media: RPMI 1640 0.5 L (Fisher Scientific, Cat#MT10041CV) + CDM3 supplement 5 mL. CDM3 is stable at 4°C for >4 weeks.Note: Optional supplementation with 4 μg/mL insulin (Sigma Aldrich, Cat#I9278) and 1 mg/mL polyvinyl alcohol (PVA) from d0-d8 greatly improves cell viability, cardiomyocyte yield and consistency. Before adding CDM3 supplement, add 0.5 g PVA to 500 mL RPMI 1640 and allow to solubilize at room temperature for a few hours, sterile filter and add 10 mM HEPES, CDM3 supplement and 4 μg/mL insulin. Use GiWi protocol to efficiently differentiate ES/iPSCs into cardiomyocytes (Figure 2). Before you begin make CDM3 media:a.CDM3 supplement:i.Slowly add 1.056 g of L-ascorbic acid 2-phosphate (Wako, Cat#USA321-44823) to 50 mL millipore water.ii.Mix intermittently until clear.iii.Add 2.5 g of recombinant human albumin (ScienCell, Cat#OsrHSA), and mix until dissolved.b.Sterilize media using Stericup 0.22 μm vacuum filter (EMD Millipore, Cat#4805)c.Make 5 mL aliquots in 15 mL Falcon tubes and store at −20°C.d.CDM3 complete media: RPMI 1640 0.5 L (Fisher Scientific, Cat#MT10041CV) + CDM3 supplement 5 mL. CDM3 is stable at 4°C for >4 weeks.Note: Optional supplementation with 4 μg/mL insulin (Sigma Aldrich, Cat#I9278) and 1 mg/mL polyvinyl alcohol (PVA) from d0-d8 greatly improves cell viability, cardiomyocyte yield and consistency. Before adding CDM3 supplement, add 0.5 g PVA to 500 mL RPMI 1640 and allow to solubilize at room temperature for a few hours, sterile filter and add 10 mM HEPES, CDM3 supplement and 4 μg/mL insulin. a.CDM3 supplement:i.Slowly add 1.056 g of L-ascorbic acid 2-phosphate (Wako, Cat#USA321-44823) to 50 mL millipore water.ii.Mix intermittently until clear.iii.Add 2.5 g of recombinant human albumin (ScienCell, Cat#OsrHSA), and mix until dissolved. CDM3 supplement:i.Slowly add 1.056 g of L-ascorbic acid 2-phosphate (Wako, Cat#USA321-44823) to 50 mL millipore water.ii.Mix intermittently until clear.iii.Add 2.5 g of recombinant human albumin (ScienCell, Cat#OsrHSA), and mix until dissolved. i.Slowly add 1.056 g of L-ascorbic acid 2-phosphate (Wako, Cat#USA321-44823) to 50 mL millipore water. Slowly add 1.056 g of L-ascorbic acid 2-phosphate (Wako, Cat#USA321-44823) to 50 mL millipore water. ii.Mix intermittently until clear. Mix intermittently until clear. iii.Add 2.5 g of recombinant human albumin (ScienCell, Cat#OsrHSA), and mix until dissolved. Add 2.5 g of recombinant human albumin (ScienCell, Cat#OsrHSA), and mix until dissolved. b.Sterilize media using Stericup 0.22 μm vacuum filter (EMD Millipore, Cat#4805) Sterilize media using Stericup 0.22 μm vacuum filter (EMD Millipore, Cat#4805) c.Make 5 mL aliquots in 15 mL Falcon tubes and store at −20°C. Make 5 mL aliquots in 15 mL Falcon tubes and store at −20°C. d.CDM3 complete media: RPMI 1640 0.5 L (Fisher Scientific, Cat#MT10041CV) + CDM3 supplement 5 mL. CDM3 is stable at 4°C for >4 weeks.Note: Optional supplementation with 4 μg/mL insulin (Sigma Aldrich, Cat#I9278) and 1 mg/mL polyvinyl alcohol (PVA) from d0-d8 greatly improves cell viability, cardiomyocyte yield and consistency. Before adding CDM3 supplement, add 0.5 g PVA to 500 mL RPMI 1640 and allow to solubilize at room temperature for a few hours, sterile filter and add 10 mM HEPES, CDM3 supplement and 4 μg/mL insulin. CDM3 complete media: RPMI 1640 0.5 L (Fisher Scientific, Cat#MT10041CV) + CDM3 supplement 5 mL. CDM3 is stable at 4°C for >4 weeks.Note: Optional supplementation with 4 μg/mL insulin (Sigma Aldrich, Cat#I9278) and 1 mg/mL polyvinyl alcohol (PVA) from d0-d8 greatly improves cell viability, cardiomyocyte yield and consistency. Before adding CDM3 supplement, add 0.5 g PVA to 500 mL RPMI 1640 and allow to solubilize at room temperature for a few hours, sterile filter and add 10 mM HEPES, CDM3 supplement and 4 μg/mL insulin. Note: Optional supplementation with 4 μg/mL insulin (Sigma Aldrich, Cat#I9278) and 1 mg/mL polyvinyl alcohol (PVA) from d0-d8 greatly improves cell viability, cardiomyocyte yield and consistency. Before adding CDM3 supplement, add 0.5 g PVA to 500 mL RPMI 1640 and allow to solubilize at room temperature for a few hours, sterile filter and add 10 mM HEPES, CDM3 supplement and 4 μg/mL insulin. 30.Day 0 of differentiation: CDM3-C: prepare sufficient CDM3-C by adding CHIR99021 (Fisher Scientific, Cat#50-202-8603) at a final concentration of 3–4 μM to CDM3 complete medium and warm at 37°C. Aspirate medium and add 5 mL of CDM3-C. Day 0 of differentiation: CDM3-C: prepare sufficient CDM3-C by adding CHIR99021 (Fisher Scientific, Cat#50-202-8603) at a final concentration of 3–4 μM to CDM3 complete medium and warm at 37°C. Aspirate medium and add 5 mL of CDM3-C. Note: Both plating density and CHIR99021 concentration should be optimized for maximal differentiation efficiency and consistency. Note: Without the addition of insulin, significant cell death will be noted; hPSCs that undergo epithelial to mesenchymal transition will result in higher cardiomyocyte yield than those that maintain an epithelial morphology. 31.Day 2: CDM3-C59: Prepare sufficient CDM3-C59 media by adding Wnt-C59 (Sigma Aldrich, Cat#500496000) at a final concentration of 2 μM to CDM3 complete medium and warm at 37°C. At 48 h, aspirate medium and add 5 mL of CDM3-C59. Day 2: CDM3-C59: Prepare sufficient CDM3-C59 media by adding Wnt-C59 (Sigma Aldrich, Cat#500496000) at a final concentration of 2 μM to CDM3 complete medium and warm at 37°C. At 48 h, aspirate medium and add 5 mL of CDM3-C59. Note: For optimal differentiation, be sure to replace the media at the same time every two days 32.Day 4 and 6: At 96 h and day 6, aspirate medium from wells and add 5 mL of CDM3 complete medium. Day 4 and 6: At 96 h and day 6, aspirate medium from wells and add 5 mL of CDM3 complete medium. 33.Day 8 and 10: Selection media: RPMI 1640 0.5 L + B27 supplement 10 mL. Selection media is stable at 4°C for >2 weeks. Aspirate medium from wells and add 2 mL of selection media. Day 8 and 10: Selection media: RPMI 1640 0.5 L + B27 supplement 10 mL. Selection media is stable at 4°C for >2 weeks. Aspirate medium from wells and add 2 mL of selection media. 34.On Day 8, take small aliquot of differentiating cells to perform QC of sgRNA coverage using long read nanopore sequencer (follow protocol in step 18). This ensures sgRNA coverage is optimal and not enriched/depleted of large subpools of guides. On Day 8, take small aliquot of differentiating cells to perform QC of sgRNA coverage using long read nanopore sequencer (follow protocol in step 18). This ensures sgRNA coverage is optimal and not enriched/depleted of large subpools of guides. Note: Metabolic purification can be started on day 8 or at first onset of spontaneous beating. At least 4 days of metabolic selection may be required. Some non-cardiomyocyte cell types can survive metabolic selection. Supplementation with 4 μg/mL insulin and 1 mg/mL polyvinyl alcohol greatly improves differentiation purity and typically does not require selection. 35.Day 12: Harvest CMs for scRNA-seqa.Add 10× TrypLE (Gibco, Cat#12563-029) to digest differentiated CMs. Use 1mL per 6 well.b.Incubate at 37°C for 1 h.c.Make resuspension media using RPMI+B27+10% Knock out serum replacement KOSR (Gibco, Cat#10828028) + Rock inhibitor. Using resuspension media, dissociate CMs and pipette gently 8–10 times to break down CMs into single cells.d.Spin down CMs in benchtop centrifuge at 1500 rpm for 5–7 min.e.Discard supernatant and resuspend CMs in resuspension media.f.Count and use the appropriate number of cells for the next step. Day 12: Harvest CMs for scRNA-seqa.Add 10× TrypLE (Gibco, Cat#12563-029) to digest differentiated CMs. Use 1mL per 6 well.b.Incubate at 37°C for 1 h.c.Make resuspension media using RPMI+B27+10% Knock out serum replacement KOSR (Gibco, Cat#10828028) + Rock inhibitor. Using resuspension media, dissociate CMs and pipette gently 8–10 times to break down CMs into single cells.d.Spin down CMs in benchtop centrifuge at 1500 rpm for 5–7 min.e.Discard supernatant and resuspend CMs in resuspension media.f.Count and use the appropriate number of cells for the next step. a.Add 10× TrypLE (Gibco, Cat#12563-029) to digest differentiated CMs. Use 1mL per 6 well. Add 10× TrypLE (Gibco, Cat#12563-029) to digest differentiated CMs. Use 1mL per 6 well. b.Incubate at 37°C for 1 h. Incubate at 37°C for 1 h. c.Make resuspension media using RPMI+B27+10% Knock out serum replacement KOSR (Gibco, Cat#10828028) + Rock inhibitor. Using resuspension media, dissociate CMs and pipette gently 8–10 times to break down CMs into single cells. Make resuspension media using RPMI+B27+10% Knock out serum replacement KOSR (Gibco, Cat#10828028) + Rock inhibitor. Using resuspension media, dissociate CMs and pipette gently 8–10 times to break down CMs into single cells. d.Spin down CMs in benchtop centrifuge at 1500 rpm for 5–7 min. Spin down CMs in benchtop centrifuge at 1500 rpm for 5–7 min. e.Discard supernatant and resuspend CMs in resuspension media. Discard supernatant and resuspend CMs in resuspension media. f.Count and use the appropriate number of cells for the next step. Count and use the appropriate number of cells for the next step. CM differentiation steps Schematic showing timing and small molecules added to differentiate pluripotent stem cells towards cardiomyocyte cell state. Protocol for cell hashing Timing: ∼1 day To minimize costs associated with scRNA-seq, we perform cell hashing and super-loading of cells during library preparation for scRNA-seq. 60 k cells per library are recovered instead of 20 k cells indicated in the kit. 36.Harvest differentiated cardiomyocytes into single-cell suspension. Harvest differentiated cardiomyocytes into single-cell suspension. 37.Resuspend 10–13 million harvested cells in 1 mL staining buffer (1% BSA in 50% PBS/50% culture media) in 1.5 mL Eppendorf tube. Resuspend 10–13 million harvested cells in 1 mL staining buffer (1% BSA in 50% PBS/50% culture media) in 1.5 mL Eppendorf tube. 38.Dilute 1 μL (0.5 μg) TotalSeq-C anti-human Hashtag Antibody (BioLegend) to 5 μL staining buffer in a 200 μL PCR strip on ice. Repeat for a total of 12 unique Hashtag antibodies.a.Aliquot 50 μL of cell suspension to each Hashtag-Ab PCR tube, mix and incubate at 4°C with rotation for 20 min.b.Add 150 μL staining buffer to each tube and centrifuge at 275 g for 5 min.c.Remove supernatant and add 200 μL staining buffer to each tube. Mix and transfer cell suspensions to a 15 mL tube with 5 mL staining buffer on ice. Centrifuge the 15 mL tube at 275 g for 5 min.d.Wash the cells in the 15 mL tube with a 7 mL ice-cold staining buffer once.e.Wash the cells in the 15 mL tube with 7 mL of ice-cold 1% BSA in PBS once. Count cell concentration to determine how much volume should be added in the next step.f.Resuspend cells in ice-cold 1% BSA in PBS at a concentration of 5–6 million cells/mL.g.Filter the cell suspension with 30 μm Pre-Separation filters (Miltenyi Biotec, Cat#130-041-407). This removes cell debris and retains cardiomyocytes.h.Count the cells. Ensure cell viability is above 70% and cells are in a single-cell suspension.Note: There are no super-loading 10× 5′ HT kits for CRISPR Screening & Cell Multiplexing available on the market. 5′ HT libraries were prepared with 10× 5′ HT reagent kits with Feature Barcode technology for CRISPR Screening & Cell Surface Protein. Super-loading as per protocol below helps recover more cells after sequencing:i.For cardiomyocytes, load 173 k cells to target 60 k recovered cells.ii.For other stem-cell derived cells, load 115 k cells to target 60 k recovered cells. Dilute 1 μL (0.5 μg) TotalSeq-C anti-human Hashtag Antibody (BioLegend) to 5 μL staining buffer in a 200 μL PCR strip on ice. Repeat for a total of 12 unique Hashtag antibodies.a.Aliquot 50 μL of cell suspension to each Hashtag-Ab PCR tube, mix and incubate at 4°C with rotation for 20 min.b.Add 150 μL staining buffer to each tube and centrifuge at 275 g for 5 min.c.Remove supernatant and add 200 μL staining buffer to each tube. Mix and transfer cell suspensions to a 15 mL tube with 5 mL staining buffer on ice. Centrifuge the 15 mL tube at 275 g for 5 min.d.Wash the cells in the 15 mL tube with a 7 mL ice-cold staining buffer once.e.Wash the cells in the 15 mL tube with 7 mL of ice-cold 1% BSA in PBS once. Count cell concentration to determine how much volume should be added in the next step.f.Resuspend cells in ice-cold 1% BSA in PBS at a concentration of 5–6 million cells/mL.g.Filter the cell suspension with 30 μm Pre-Separation filters (Miltenyi Biotec, Cat#130-041-407). This removes cell debris and retains cardiomyocytes.h.Count the cells. Ensure cell viability is above 70% and cells are in a single-cell suspension.Note: There are no super-loading 10× 5′ HT kits for CRISPR Screening & Cell Multiplexing available on the market. 5′ HT libraries were prepared with 10× 5′ HT reagent kits with Feature Barcode technology for CRISPR Screening & Cell Surface Protein. Super-loading as per protocol below helps recover more cells after sequencing:i.For cardiomyocytes, load 173 k cells to target 60 k recovered cells.ii.For other stem-cell derived cells, load 115 k cells to target 60 k recovered cells. a.Aliquot 50 μL of cell suspension to each Hashtag-Ab PCR tube, mix and incubate at 4°C with rotation for 20 min. Aliquot 50 μL of cell suspension to each Hashtag-Ab PCR tube, mix and incubate at 4°C with rotation for 20 min. b.Add 150 μL staining buffer to each tube and centrifuge at 275 g for 5 min. Add 150 μL staining buffer to each tube and centrifuge at 275 g for 5 min. c.Remove supernatant and add 200 μL staining buffer to each tube. Mix and transfer cell suspensions to a 15 mL tube with 5 mL staining buffer on ice. Centrifuge the 15 mL tube at 275 g for 5 min. Remove supernatant and add 200 μL staining buffer to each tube. Mix and transfer cell suspensions to a 15 mL tube with 5 mL staining buffer on ice. Centrifuge the 15 mL tube at 275 g for 5 min. d.Wash the cells in the 15 mL tube with a 7 mL ice-cold staining buffer once. Wash the cells in the 15 mL tube with a 7 mL ice-cold staining buffer once. e.Wash the cells in the 15 mL tube with 7 mL of ice-cold 1% BSA in PBS once. Count cell concentration to determine how much volume should be added in the next step. Wash the cells in the 15 mL tube with 7 mL of ice-cold 1% BSA in PBS once. Count cell concentration to determine how much volume should be added in the next step. f.Resuspend cells in ice-cold 1% BSA in PBS at a concentration of 5–6 million cells/mL. Resuspend cells in ice-cold 1% BSA in PBS at a concentration of 5–6 million cells/mL. g.Filter the cell suspension with 30 μm Pre-Separation filters (Miltenyi Biotec, Cat#130-041-407). This removes cell debris and retains cardiomyocytes. Filter the cell suspension with 30 μm Pre-Separation filters (Miltenyi Biotec, Cat#130-041-407). This removes cell debris and retains cardiomyocytes. h.Count the cells. Ensure cell viability is above 70% and cells are in a single-cell suspension.Note: There are no super-loading 10× 5′ HT kits for CRISPR Screening & Cell Multiplexing available on the market. 5′ HT libraries were prepared with 10× 5′ HT reagent kits with Feature Barcode technology for CRISPR Screening & Cell Surface Protein. Super-loading as per protocol below helps recover more cells after sequencing:i.For cardiomyocytes, load 173 k cells to target 60 k recovered cells.ii.For other stem-cell derived cells, load 115 k cells to target 60 k recovered cells. Count the cells. Ensure cell viability is above 70% and cells are in a single-cell suspension.Note: There are no super-loading 10× 5′ HT kits for CRISPR Screening & Cell Multiplexing available on the market. 5′ HT libraries were prepared with 10× 5′ HT reagent kits with Feature Barcode technology for CRISPR Screening & Cell Surface Protein. Super-loading as per protocol below helps recover more cells after sequencing:i.For cardiomyocytes, load 173 k cells to target 60 k recovered cells.ii.For other stem-cell derived cells, load 115 k cells to target 60 k recovered cells. Note: There are no super-loading 10× 5′ HT kits for CRISPR Screening & Cell Multiplexing available on the market. 5′ HT libraries were prepared with 10× 5′ HT reagent kits with Feature Barcode technology for CRISPR Screening & Cell Surface Protein. Super-loading as per protocol below helps recover more cells after sequencing: i.For cardiomyocytes, load 173 k cells to target 60 k recovered cells. For cardiomyocytes, load 173 k cells to target 60 k recovered cells. ii.For other stem-cell derived cells, load 115 k cells to target 60 k recovered cells. For other stem-cell derived cells, load 115 k cells to target 60 k recovered cells. Construction of scRNA-seq libraries Timing: ∼1–2 days Generate libraries for single cell RNA sequencing. 39.Construct sgRNA and HTO libraries during scRNA-Seq.a.Prepare transcriptome, sgRNA, and HTO libraries according to 10× CG000513 protocol with some modifications.b.For transcription libraries follow the protocol CG000513 Step 5: 5′ Gene Expression Library Construction.c.For sgRNA libraries follow the protocol CG000513 Step 6: CRISPR Screening Library Construction, except 4 times the input sgRNA cDNA recommended were used:i.CG000513 step 6.1.j ∼6.1.m: Elute with 20.5 μL instead of 40.5 μL.ii.CG000513 part 6.2.b: Add 10 μL (instead 5 μL) Guide RNA cDNA Cleanup for each PCR reaction. Add 40 μL (instead 45 μL) Feature S1 primers 4 for each PCR reaction.iii.CG000513 part 6.2.e and 6.4.d Increase the PCR cycles from 10 to 11.d.For HTO libraries follow the protocol CG000513 Step 7: Cell Surface Protein Library Construction without modification. TotalSeq anti-human Hashtag reagents (BioLegend) are designed to label most human cells, using a combination of two clones that recognize cell surface protein CD298 and β2 microglobulin, respectively.e.Measure the library concentration with Qubit reagents (Thermo Fisher Scientific) and analyze the peak size of the libraries with TapeStation System (Agilent Technologies). Construct sgRNA and HTO libraries during scRNA-Seq.a.Prepare transcriptome, sgRNA, and HTO libraries according to 10× CG000513 protocol with some modifications.b.For transcription libraries follow the protocol CG000513 Step 5: 5′ Gene Expression Library Construction.c.For sgRNA libraries follow the protocol CG000513 Step 6: CRISPR Screening Library Construction, except 4 times the input sgRNA cDNA recommended were used:i.CG000513 step 6.1.j ∼6.1.m: Elute with 20.5 μL instead of 40.5 μL.ii.CG000513 part 6.2.b: Add 10 μL (instead 5 μL) Guide RNA cDNA Cleanup for each PCR reaction. Add 40 μL (instead 45 μL) Feature S1 primers 4 for each PCR reaction.iii.CG000513 part 6.2.e and 6.4.d Increase the PCR cycles from 10 to 11.d.For HTO libraries follow the protocol CG000513 Step 7: Cell Surface Protein Library Construction without modification. TotalSeq anti-human Hashtag reagents (BioLegend) are designed to label most human cells, using a combination of two clones that recognize cell surface protein CD298 and β2 microglobulin, respectively.e.Measure the library concentration with Qubit reagents (Thermo Fisher Scientific) and analyze the peak size of the libraries with TapeStation System (Agilent Technologies). a.Prepare transcriptome, sgRNA, and HTO libraries according to 10× CG000513 protocol with some modifications. Prepare transcriptome, sgRNA, and HTO libraries according to 10× CG000513 protocol with some modifications. b.For transcription libraries follow the protocol CG000513 Step 5: 5′ Gene Expression Library Construction. For transcription libraries follow the protocol CG000513 Step 5: 5′ Gene Expression Library Construction. c.For sgRNA libraries follow the protocol CG000513 Step 6: CRISPR Screening Library Construction, except 4 times the input sgRNA cDNA recommended were used:i.CG000513 step 6.1.j ∼6.1.m: Elute with 20.5 μL instead of 40.5 μL.ii.CG000513 part 6.2.b: Add 10 μL (instead 5 μL) Guide RNA cDNA Cleanup for each PCR reaction. Add 40 μL (instead 45 μL) Feature S1 primers 4 for each PCR reaction.iii.CG000513 part 6.2.e and 6.4.d Increase the PCR cycles from 10 to 11. For sgRNA libraries follow the protocol CG000513 Step 6: CRISPR Screening Library Construction, except 4 times the input sgRNA cDNA recommended were used:i.CG000513 step 6.1.j ∼6.1.m: Elute with 20.5 μL instead of 40.5 μL.ii.CG000513 part 6.2.b: Add 10 μL (instead 5 μL) Guide RNA cDNA Cleanup for each PCR reaction. Add 40 μL (instead 45 μL) Feature S1 primers 4 for each PCR reaction.iii.CG000513 part 6.2.e and 6.4.d Increase the PCR cycles from 10 to 11. i.CG000513 step 6.1.j ∼6.1.m: Elute with 20.5 μL instead of 40.5 μL. CG000513 step 6.1.j ∼6.1.m: Elute with 20.5 μL instead of 40.5 μL. ii.CG000513 part 6.2.b: Add 10 μL (instead 5 μL) Guide RNA cDNA Cleanup for each PCR reaction. Add 40 μL (instead 45 μL) Feature S1 primers 4 for each PCR reaction. CG000513 part 6.2.b: Add 10 μL (instead 5 μL) Guide RNA cDNA Cleanup for each PCR reaction. Add 40 μL (instead 45 μL) Feature S1 primers 4 for each PCR reaction. iii.CG000513 part 6.2.e and 6.4.d Increase the PCR cycles from 10 to 11. CG000513 part 6.2.e and 6.4.d Increase the PCR cycles from 10 to 11. d.For HTO libraries follow the protocol CG000513 Step 7: Cell Surface Protein Library Construction without modification. TotalSeq anti-human Hashtag reagents (BioLegend) are designed to label most human cells, using a combination of two clones that recognize cell surface protein CD298 and β2 microglobulin, respectively. For HTO libraries follow the protocol CG000513 Step 7: Cell Surface Protein Library Construction without modification. TotalSeq anti-human Hashtag reagents (BioLegend) are designed to label most human cells, using a combination of two clones that recognize cell surface protein CD298 and β2 microglobulin, respectively. e.Measure the library concentration with Qubit reagents (Thermo Fisher Scientific) and analyze the peak size of the libraries with TapeStation System (Agilent Technologies). Measure the library concentration with Qubit reagents (Thermo Fisher Scientific) and analyze the peak size of the libraries with TapeStation System (Agilent Technologies). High throughput sequencing and analysis Timing: ∼3–4 weeks Process the Fastq files we get from the sequencer through Pyspade to obtain analyzed data (Figure 3). A step-wise computational processing pipeline for this data, can be found at Github: https://github.com/Hon-lab/Perturb-Seq-Processing-Pipeline. This pipeline allows us to look at DEGs upon specific perturbation and interpret results. 40.Sequence scRNA-seq libraries. Sequence scRNA-seq libraries. 41.For the 3 sequencing modalities, the following number of reads are targeted during sequencing and library prep:a.Transcriptome Libraries – 600 M Reads.b.SgRNA Libraries – 140 M Reads.c.HTO Libraries – 60 M Reads. For the 3 sequencing modalities, the following number of reads are targeted during sequencing and library prep:a.Transcriptome Libraries – 600 M Reads.b.SgRNA Libraries – 140 M Reads.c.HTO Libraries – 60 M Reads. a.Transcriptome Libraries – 600 M Reads. Transcriptome Libraries – 600 M Reads. b.SgRNA Libraries – 140 M Reads. SgRNA Libraries – 140 M Reads. c.HTO Libraries – 60 M Reads. HTO Libraries – 60 M Reads. 42.We use Pyspade to analyze the data.2 After processing, we aim to obtain 1500 UMIs for sgRNA and 3000 UMIs for transcriptomes. We use Pyspade to analyze the data.2 After processing, we aim to obtain 1500 UMIs for sgRNA and 3000 UMIs for transcriptomes. Schematic of data processing pipeline Figure showing computational pipeline from sequencing to generation of final transcriptome outputs using Pyspade. Expected outcomes The perturb-seq sgRNA library includes positive controls that repress target genes specifically but don’t alter differentiation and non-targeting controls that don’t repress any region in the human genome. We also include sgRNAs against cardiac specific genes which when repressed are known to alter cardiac differentiation. When pipeline is working efficiently, perturb-seq output from 1) non-targeting sgRNAs should show upregulation of cardiac specific markers such as Tnnt2, 2) positive control sgRNA should show repression of target gene and upregulation of cardiac specific markers, and 3) repression of cardiac specific genes should repress target gene and retrieve downstream differentially regulated transcripts. These controls ensure that biological and technical aspects of pipeline works and outputs from test gene repression can be validated and studied further. Example of Perturb-Seq outputs can be found in.1 Limitations Perturb-Seq works well to identify regulators of developmental processes at distinct times. Perturbations that cause cell death will drop out from the screen and perturbations that promote cell proliferation will be enriched in cell number during this screen. Careful sgRNA coverage monitoring during the experiment is critical to obtain uniform numbers of perturbed cells after the screen. Perturb-seq is useful to understand cell autonomous effects, but non-cell autonomous effects are more difficult to capture during Perturb-Seq. Troubleshooting Problem 1 Too much cell death after lentiviral infection in part 4. Potential solution If viral titer is too high, it can cause death in PSCs. It is important to carefully titer the virus and infect at MOI that is low or medium to avoid cell death and preserve health of PSCs. Problem 2 Cell death after single cell dissociation during FACS sorting in part 5. Potential solution PSCs are very sensitive to single cell dissociation and FACS sorting. We add CloneR2 for a few hours before preparing cells for sorting to ensure increased cell viability and better cell recovery after cell sorting. Problem 3 Cardiomyocyte differentiation is not efficient in part 6. Potential solution Every PSC line requires optimization to differentiate into CMs. Usually, Chir99021 concentration varies by cell line and starting density. Testing different combinations of this will be useful to optimize differentiation. Problem 4 Cardiomyocytes are not pelleting after collection in part 6. Potential solution Cardiomyocytes tend to stick to each other. Use of 10× TrypLE for 1 h followed by pipetting helps break down CMs into single cells. If this is not sufficient, one can incubate longer in TrypLE to potentiate single cell dissociation. Problem 5 Recovery of cells after scRNA-seq that don’t have sgRNA in part 9. Potential solution This can be due to several reasons. After lentiviral library infection, it is important to select for cells that have lentivirus using selection markers on the lentivirus. Skipping this step can lead to PSCs that do not have sgRNA. Sorting differentiated cardiomyocytes for the presence of sgRNA before scRNA-seq ensures sequenced CMs have sgRNAs. Another reason is if sgRNA capture before scRNA-seq is inefficient than that can cause cell recovery without sgRNA. So, it is important to optimize sgRNA capture before doing a large-scale experiment. Resource availability Lead contact Further information and requests for resources and reagents can be directed to Nikhil V. Munshi (nikhil.munshi@utsouthwestern.edu) or Gary C. Hon (gary.hon@utsouthwestern.edu). Technical contact Technical questions on protocol execution or steps must be directed to the technical contacts, Nikhil V. Munshi (nikhil.munshi@utsouthwestern.edu) or Gary C. Hon (gary.hon@utsouthwestern.edu). Materials availability Any cell lines generated by this study will be deposited in Wicell for distribution. Any plasmids that are part of this study have been deposited in Addgene. Other reagents can be obtained by contacting the lead contact. Data and code availability All data and code generated as part of this study are available at IGVF data portal. Acknowledgments We acknowledge the BioHPC computational infrastructure at UT Southwestern for providing high performance computing and storage resources for the success of this project. G.C.H. is supported by CPRIT (RP190451), NIH (DP2GM128203 and UM1HG011996), the Burroughs Wellcome Fund (1019804), and the Green Center for Reproductive Biology. N.V.M. is supported by the NIH (HL136604, HL151650, HG012768, and HG011996), the Burroughs Wellcome Fund (1009838), and the Department of Defense (PR172060). We thank members of the Hon and Munshi laboratories at UTSW for critical suggestions and members of the IGVF consortium for methodological feedback. Author contributions L.W. constructed plasmid libraries, built scRNA-seq libraries, and performed molecular cloning. H.Z. made lentiviral libraries, infected PSCs and FACS-sorted PSCs. M.D. performed qPCR and maintained PSCs. S.S. differentiated PSCs and validated screen hits. D.C.P. made figures and performed molecular cloning. C.T. designed sgRNAs based on targets. N.V.M. and G.C.H. supervised the project and wrote the manuscript with input from other authors. Declaration of interests The authors declare no competing interests. Contributor Information Sushama Sivakumar, Email: sushama.sivakumar@utsouthwestern.edu. Gary C. Hon, Email: gary.hon@utsouthwestern.edu. Nikhil V. Munshi, Email: nikhil.munshi@utsouthwestern.edu. References Associated Data Data Availability Statement All data and code generated as part of this study are available at IGVF data portal.